Knee Orthosis for Knee Arthritis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new type of knee brace, called a medial joint distraction brace, designed to aid individuals with knee arthritis, specifically in the inner or outer part of the knee joint. The researchers aim to determine if wearing this brace for 12 weeks can reduce pain and improve mobility. It is suitable for those diagnosed with medial or lateral knee arthritis, who can walk with or without assistance, and have a body mass index (BMI) under 35. Participants will wear the brace and regularly report on their pain and usage. As an unphased trial, this study allows participants to contribute to innovative research that could enhance arthritis treatment options.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this knee orthosis is safe for treating knee arthritis?
Research has shown that the Adonis joint distraction brace is generally safe for individuals with knee osteoarthritis. One study found that this brace has a good safety record, causing few, if any, serious side effects. Patients found it easy to use and comfortable, adhering well to the treatment plan. Another study noted that the brace improved joint spacing and reduced pain. Thus, wearing the brace not only alleviates symptoms but is also well-tolerated by patients. Overall, evidence suggests that the brace is a safe option for managing knee arthritis.12345
Why are researchers excited about this trial?
Unlike standard treatments for knee arthritis, which often include medications or surgery, the medial joint distraction brace offers a non-invasive alternative. This brace works by gently separating the knee joint, potentially reducing pain and improving function without the need for drugs or surgical intervention. Researchers are excited because this novel approach could provide relief and improve quality of life for patients with medial knee osteoarthritis, especially those looking to avoid more invasive procedures.
What evidence suggests that this knee orthosis is effective for knee arthritis?
Research has shown that the Adonis joint distraction brace, used by participants in this trial, can increase space in the knee joint, reduce pain, and improve movement for individuals with knee osteoarthritis. Early results suggest that the brace relieves pressure on the knee, reducing stress on the joint. Users of this brace have reported less pain and improved mobility. Evidence also indicates that people are willing and able to use the brace regularly. Although some studies have mixed results, overall, the brace appears to be a promising non-invasive option for managing knee osteoarthritis symptoms.12346
Are You a Good Fit for This Trial?
This trial is for adults aged 30-70 with knee osteoarthritis in one part of the knee, who can walk (with or without help), have a BMI under 35, and are able to use a brace on one leg. Participants must be willing to attend visits and fill out English questionnaires.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the Icarus Adonis Joint Distraction brace and document usage and pain scores
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Medial joint distraction brace
Trial Overview
The study is testing a new type of knee brace designed to relieve pressure in the affected area for people with medial knee osteoarthritis. The goal is to see if this novel joint distraction orthosis helps reduce pain and improve function.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Patients experiencing unicompartment (medial or lateral) osteoarthritis will receive Icarus Adonis Joint Distraction brace. Patients will wear the brace for 12 weeks and document how often they wear the brace and their pain scores. Patients will fill out outcome surveys at 2, 4, 6, 8, and 12 weeks.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Icarus Medical Innovations
Lead Sponsor
Citations
1.
icarusmedical.com
icarusmedical.com/technical-briefings/patient-outcomes-for-a-novel-joint-distraction-brace-for-tibiofemoral-oa/Patient Outcomes for a Novel Joint Distraction Brace
This pilot study highlights how the Adonis joint distraction brace improves joint spacing, reduces pain, and enhances function in patients ...
The Effect of a Novel Joint Distraction Knee Orthosis for ...
Patients experiencing unicompartment (medial or lateral) osteoarthritis will receive Icarus Adonis Joint Distraction brace. Patients will wear the brace for ...
Medial Adonis White Paper
5 These braces aim to reduce joint forces, however, clinical studies have shown mixed results regarding their efficacy and fail to show clinical significance in ...
Clinical effectiveness and safety of a distraction-rotation ...
Conclusion: This new unloader brace appeared to have good effect on medial knee OA, with an acceptable safety profile and good patient compliance. Keywords: ...
5.
einpresswire.com
einpresswire.com/article/782915293/icarus-medical-launches-the-adonis-knee-brace-a-breakthrough-in-osteoarthritis-managementIcarus Medical Launches the Adonis Knee Brace, a ...
The Adonis Knee Brace introduces a new approach to managing knee osteoarthritis by incorporating a dynamic Joint Distraction hinge, which ...
Knee Orthosis for Knee Arthritis · Info for Participants
Patients experiencing unicompartment (medial or lateral) osteoarthritis will receive Icarus Adonis Joint Distraction brace. Patients will wear the brace for ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.